Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Companion Animal Health Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of pet diseases
3.2.1.2. Growing uptake of pet insurance
3.2.1.3. Increasing pet population
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced treatment
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. U.S. Companion Animal Health Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Product Pipeline Analysis
3.3.6. Estimated Number of pet popultion in U.S., 2018-2024
3.3.7. COVID-19 Impact Analysis
Chapter 4. U.S. Companion Animal Health Market: Animal type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Companion Animal Health Market: Animal type Movement Analysis & Market Share, 2024 & 2030
4.3. Dogs
4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cats
4.4.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Equine
4.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Companion Animal Health Market: Product Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Companion Animal Health Market: Product Movement Analysis & Market Share, 2024 & 2030
5.3. Biologics
5.3.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Vaccines
5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.2. Modified/ Attenuated Live
5.3.2.2.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.3. Inactivated (Killed)
5.3.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.4. Other Vaccines
5.3.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Other Biologics
5.3.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Pharmaceuticals
5.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Parasiticides
5.4.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Anti-infectives
5.4.3.1. Anti-Infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Anti-Inflammatory
5.4.4.1. Anti-Inflammatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Analgesics
5.4.5.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Others
5.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Supplements
5.5.1. Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Diagnostics
5.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Companion Animal Health Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
6.3. Retail
6.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. E-Commerce
6.4.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Hospital/ Clinic Pharmacies
6.5.1. Hospital/ Clinic Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Companion Animal Health Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Companion Animal Health Market: End Use Movement Analysis & Market Share, 2024 & 2030
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Point-of-Care
7.4.1. Point-of-Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heap Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co., Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Elanco
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Boehringer Ingelheim GmbH
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Ceva Sant? Animale
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Zoetis
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Virbac
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. IDEXX
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Mars Inc.
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Dechra Pharmaceuticals Plc (EQT)
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Vetoquinol S.A.
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives



List of Figures

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 U.S. Companion Animal Health market revenue, 2018 - 2030 (USD Million)
Fig. 10 U.S. Companion Animal Health market snapshot
Fig. 11 U.S Companion Animal Health market driver impact
Fig. 12 U.S Companion Animal Health market restraint impact
Fig. 13 Porter’s 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 U.S Companion Animal Health market animal type key takeaways (USD Million)
Fig. 16 U.S Companion Animal Health market: animal type movement analysis
Fig. 17 U.S dogs market, 2018 - 2030 (USD Million)
Fig. 18 U.S cats market, 2018 - 2030 (USD Million)
Fig. 19 U.S equine market, 2018 - 2030 (USD Million)
Fig. 20 U.S others market, 2018 - 2030 (USD Million)
Fig. 21 U.S Companion Animal Health product key takeaways (USD Million)
Fig. 22 U.S Companion Animal Health market: product movement analysis
Fig. 23 U.S biologics market, 2018 - 2030 (USD Million)
Fig. 24 U.S vaccines market, 2018 - 2030 (USD Million)
Fig. 25 U.S Modified/ Attenuated Live market, 2018 - 2030 (USD Million)
Fig. 26 U.S Inactivated (Killed) market, 2018 - 2030 (USD Million)
Fig. 27 U.S Other vaccines market, 2018 - 2030 (USD Million)
Fig. 28 U.S other biologics market, 2018 - 2030 (USD Million)
Fig. 29 U.S pharamceuticals market, 2018 - 2030 (USD Million)
Fig. 30 U.S parasiticides market, 2018 - 2030 (USD Million)
Fig. 31 U.S Anti-infectives market, 2018 - 2030 (USD Million)
Fig. 32 U.S Anti-inflammatory market, 2018 - 2030 (USD Million)
Fig. 33 U.S Analgesics market, 2018 - 2030 (USD Million)
Fig. 34 U.S supplements market, 2018 - 2030 (USD Million)
Fig. 35 U.S diagnostics market, 2018 - 2030 (USD Million)
Fig. 36 U.S others market, 2018 - 2030 (USD Million)
Fig. 37 U.S Companion Animal Health market distribution channel key takeaways (USD Million)
Fig. 38 U.S Companion Animal Health market: distribution channel movement analysis
Fig. 39 U.S retail market, 2018 - 2030 (USD Million)
Fig. 40 U.S e-commerce market, 2018 - 2030 (USD Million)
Fig. 41 U.S Hospital/ Clinic Pharmacies market, 2018 - 2030 (USD Million)
Fig. 42 U.S Companion Animal Health market end use key takeaways (USD Million)
Fig. 43 U.S Companion Animal Health market: end use movement analysis
Fig. 44 U.S Hospitals & Clinics market, 2018 - 2030 (USD Million)
Fig. 45 U.S Point-of-Care market, 2018 - 2030 (USD Million)
Fig. 46 U.S others market, 2018 - 2030 (USD Million)
Fig. 47 Market participant categorization
Fig. 48 Heat map analysis/Company market position analysis

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 U.S. Companion Animal Health market, by animal type, 2018 - 2030 (USD Million)
Table 3 U.S. Companion Animal Health market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. Companion Animal Health market, by distribution channel, 2018 - 2030 (USD Million)
Table 5 U.S. Companion Animal Health market, by end use, 2018 - 2030 (USD Million)
Table 6 Participant’s overview
Table 7 Financial performance
Table 8 Product benchmarking
Table 9 Strategic Initiatives